低剂量与高剂量碘-131 用于甲状腺残余消融疗效的中国数据
该研究纳入2013年1月至2014年12月间在中国接受放射性碘消融的分化型甲状腺癌术后患者327例,随机分为低剂量组1850 MBq和高剂量组3700 MBq,最终278例可分析。结果显示初始消融成功率低剂量组82.6%、高剂量组86.2%,两组无差异(p=0.509);作者结论认为在中国患者中低剂量1850 MBq与高剂量3700 MBq同样有效。
要点
- 中国分化型甲状腺癌术后患者中,低剂量1850 MBq与高剂量3700 MBq消融成功率无差异(p=0.509)。
- 全组初始消融成功率为84.2%,低剂量组82.6%,高剂量组86.2%。
- 研究共入组327例,最终278例可分析,其中低剂量组155例、高剂量组123例。
核心结论
- 在中国分化型甲状腺癌患者中,低剂量1850 MBq放射性碘与高剂量3700 MBq用于甲状腺残余消融同样有效。
研究设计与样本
- 随机对照研究,纳入2013年1月至2014年12月间在作者所在科室接受放射性碘消融的患者,年龄≥16岁,行全切或近全切,pT1-3、任何N分期、M0。
- 共入组327例,最终278例可分析(平均年龄44岁,女性71.6%),低剂量组155例,高剂量组123例。
主要发现
- 全组初始消融成功率为84.2%,低剂量组为82.6%,高剂量组为86.2%,两组无差异(p=0.509)。
- 超过95%的患者为乳头状甲状腺癌。
关键数值与推荐
- 消融成功定义为诊断性全身扫描甲状腺床无示踪剂摄取且血清甲状腺球蛋白水平阴性,于6至9个月后评估。
- 低剂量组为1850 MBq,高剂量组为3700 MBq。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chinese data on the efficacy of low- and high-dose radioiodine for thyroid remnant are still absent. The aim of the study was to investigate whether a low dose of radioiodine is as effective as a high dose for remnant ablation in Chinese patients. METHODS: Patients presenting for radioiodine ablation in the authors' department were included. Inclusion criteria were aged ≥16 years, total or near-total thyroidectomy, tumor-node-metastasis (TNM) stage of pT1-3, any N stage, and M0. All patients were randomly allocated to either the high-dose group of 3700 MBq or the low-dose group of 1850 MBq for remnant ablation. The response to treatment was defined as successful or unsuccessful after a six- to nine-month interval. Ablation was considered to be successful if patients fulfilled the following criteria: no tracer uptake in the thyroid bed on diagnosis whole-body scanning and a negative level of serum thyroglobulin. RESULTS: There were 327 patients enrolled between January 2013 and December 2014. More than 95% had papillary thyroid cancer. Data could be analyzed for 278 cases (Mage = 44 years; 71.6% women), 155 in the low-dose group and 123 in the high-dose group. The rate of initial successful ablation was 84.2% in all patients, 82.6% in the low-dose group, and 86.2% in the high-dose group. There was no difference between the two groups (p = 0.509). CONCLUSIONS: In Chinese patients with differentiated thyroid carcinoma, the low dose of 1850 MBq radioiodine activity is as effective as a high dose of 3700 MBq for thyroid remnant ablation.
引用
- Ma C, Feng F, Wang S, et al. Chinese Data of Efficacy of Low- and High-Dose Iodine-131 for the Ablation of Thyroid Remnant. Thyroid. 2017. PMID: 28401794. doi:10.1089/thy.2015.0658
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。